Clinical Trial

Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus

Study acronym: CONVERT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of real-time continuous glucose monitoring (CGM) compared with self-monitoring of blood glucose on glycemic control in adults with non-insulin treated type 2 diabetes.
Protocol Amendment History 4 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-07
notable Trial sites expanded: 0 -> 6 locations 2026-08-07
notable Primary completion pushed: 2025-09-30 -> 2026-03-14 2026-08-07
minor Completion pushed: 2026-03-31 -> 2026-12-24 2026-08-07
Trial Details
NCT Number NCT06587438
Lead Sponsor Sinocare
Conditions Diabetes Mellitus
Enrollment 160 participants
Start Date 2025-01-17
Primary Completion 2026-03-14 (estimated)
Study Completion 2026-12-24 (estimated)
Updated on ClinicalTrials.gov 2026-08-06